Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate-Reference-Cited by-同舟云学术

Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate

Published:2019-01-15 Issue:1 Volume:13 Page:93-103
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Min In Suk¹,Lee Chang Hun¹,Shin Ik Sang¹,Lee Na Eun¹,Son Hong Seon¹,Kim Seung Bum¹,Seo Seung Young¹,Kim Seong Hun¹,Kim Sang Wook¹,Lee Seung Ok¹,Lee Soo Teik¹,Kim In Hee¹

Affiliation:

1. Department of Internal Medicine, Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea

Funder

Chonbuk National University Hospital

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2019/013/ekjg013-01-16.pdf

Reference44 articles.

1. KASL clinical practice guidelines: management of chronic hepatitis B

2. Benefits and risks of nucleoside analog therapy for hepatitis B

3. Antiviral resistance and hepatitis B therapy